MedTrace Logo

Study to Estimate the Burden of Herpes Zoster (HZ) and Post-herpetic Neuralgia (PHN) in Italy

NCT01772160 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 395

Last updated 2020-05-22

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to collect data on the incidence, complications, economic burden and impact on the quality of life in adults aged ≥ 50 years with HZ disease in Italy.

Conditions

  • Herpes Zoster
  • Herpes Zoster Vaccine

Interventions

OTHER

Data collection

HZ/PHN booklet, HZ/PHN file and logbook. HZ/PHN booklet will be completed by the patient and the HZ/PHN file and logbook will be completed by the participating general practitioner.

Sponsors & Collaborators

Principal Investigators

  • GSK Clinical Trials · GlaxoSmithKline

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-02-26
Primary Completion
2016-10-05
Completion
2016-10-05

Countries

  • Italy

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01772160 on ClinicalTrials.gov